Elicio Therapeutics
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -289 | -286 | ||
EBITDA | -7,464 | -12,641 | -11,127 | -7,095 |
EBIT | -7,748 | -12,913 | -11,416 | -7,381 |
Net Income | -7,979 | -8,217 | -11,823 | -7,718 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,364 | -8,165 | -11,645 | -6,813 |
Cash | 30,900 | 23,480 | 14,948 | 18,563 |
Basic Shares | 26,291 | 19,244 | 18,211 | 15,312 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,128 | -1,178 | -1,170 | -1,057 |
EBITDA | -37,310 | -50,265 | -32,966 | -23,554 |
EBIT | -38,438 | -51,443 | -34,136 | -24,611 |
Net Income | -39,571 | -51,898 | -35,195 | -28,208 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -36,968 | -37,155 | -32,760 | -22,833 |
Cash | 18,563 | 17,618 | 12,894 | 7,797 |
Basic Shares | 15,312 | 12,202 | 5,056 | 3,100 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.30 |
2026-06-30 | -$0.43 |
2026-03-31 | -$0.65 |
2025-12-31 | -$0.49 |